Publication | Closed Access

In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)

Refractory Obsessive-compulsive DisordersPsychiatryPsychotropic MedicationClinical PsychologyPsychopharmacologyPlacebo-controlled TrialSocial SciencesPharmacotherapyAdjuvant MemantineMedicinePsychopathology